CDT EQUITY INC. Conversion of Stock, Shares Converted
CDT EQUITY INC. (CDT) had Conversion of Stock, Shares Converted of 1.00 thousand shares as of 2022-11-04, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-04-16
- 2022-11-04: Conversion of Stock, Shares Converted 1.00K shares.
| Period end | Conversion of Stock, Shares Converted |
|---|---|
| 2022-11-04 | 1.00K shares 10-K · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |